Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 21, 2025

SELL
$191.89 - $259.92 $278,624 - $377,403
-1,452 Closed
0 $0
Q4 2022

Jul 21, 2025

BUY
$197.11 - $250.07 $286,203 - $363,101
1,452 New
1,452 $316 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.11B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Credential Qtrade Securities Inc. Portfolio

Follow Credential Qtrade Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Credential Qtrade Securities Inc. with notifications on news.